Hemab Therapeutics Secures $157 Million Series C to Advance Breakthrough Treatments for Rare Bleeding Disorders Read more
Lifecore and PolyPeptide Partner to Deliver End-to-End Peptide Drug Development Solutions in the U.S. Read more
GSK Acquires Exclusive Rights to Syndivia’s Next-Generation ADC for Advanced Prostate Cancer Read more
Eli Lilly to Acquire Adverum Biotechnologies in $1.5 Billion Deal to Advance Gene Therapy for Vision Loss Read more
Takeda and Innovent Partner in $1.2 Billion Deal to Advance Late-Stage Cancer Drugs Globally Read more